Decreasing the amount she drinks would be a useful diagnostic test. If her symptoms get better immediately, it’s likely the ...

The FDA has approved the first abuse-deterrent, immediate-release, 10 mg opioid tablet for pain management, signing off on another dosage of Protega Pharmaceuticals’ Roxybond. The nod covers those ...

For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer ...

Popular liver health supplements such as milk thistle, artichoke, vitamin C, and others are marketed with unfounded claims that they "detoxify," "cleanse," and "nourish" the liver. Research suggests ...

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

To help you make healthy choices, we asked dietitians for their expert advice on how to choose the best yogurts for weight loss. How We Chose the Best Yogurts ... I suggest choosing high-protein ...

I am an 81-year-old man in reasonably good health. When I had trouble falling asleep, I would take a swig of Zzzquil, which worked perfectly every time.

The daily dose of psyllium is 3 to 10.5 grams by mouth. Agar was shown to reduce body weight ... Green tea extract doses range from 100 to 460 mg per day by mouth. As green tea contains caffeine, it ...

Find all the commercial and brand names of generic drug called Lactulose. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea ...

My wife recently underwent a successful open heart surgery with two valves repaired and one replaced. During her post-surgery recovery, she experienced an issue with the timing ...

Additional ACG presentation to focus on impact of Xifaxan on OHE rehospitalizationsLAVAL, QC / ACCESSWIRE / October 27, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology ...